Hepatitis B virus (HBV) infection is a serious public health problem worldwide.Two common genetic variants (rs3077 and rs9277535) of Human Leukocyte Antigen
The management strategy of chronic hepatitis B in patients treated with nucleos(t)ide analogues (NAs) is a topic of concern.After achieving specific endpoin